Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
- Status
- TERMINATED
- Phase
- PHASE3
Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China
- Status
- UNKNOWN
- Phase
- PHASE4
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
- Status
- UNKNOWN
- Phase
- NA
RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor
- Status
- COMPLETED
- Phase
- PHASE2
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
- Status
- COMPLETED
- Phase
- PHASE1
Intratympanic Steroid for Bell's Palsy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tolerance by Engaging Antigen During Cellular Homeostasis
- Status
- COMPLETED
- Phase
- PHASE1
CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
- Status
- COMPLETED
- Phase
- PHASE1